Explore more publications!

Blueroot Health Expands Voluntary Allergy Alert on Undeclared Egg, Hazelnut, and Soy in Vital Nutrients Aller-C Dietary Supplements

April 10, 2026 — Middletown, CT — Blueroot Health of Middletown, Connecticut is expanding its voluntary recall of its Vital Nutrients Aller-C dietary supplements due to the potential to contain undeclared egg, hazelnut, and soy. The initial recall, which included lots 25E04-A and 25E04-B, has been expanded to include all product made from lot 25E04. People who have allergies and/or severe sensitivity to egg, hazelnut, and soy run the risk of a serious or life-threatening allergic reaction if they consume this product.

Aller-C was distributed nationwide by VitalNutrients.co and other online retailers.

The recalled product is packaged in a white plastic bottle containing 100 or 200 capsules and includes lot numbers 25E04, 25E04-A, and 25E04-B with an expiration date of 05/27 on the side of the bottle.

Product
Count
UPC
Lot Numbers
Expiration Date
Vital Nutrients Aller-C
200
693465524213,
693465000090
25E04-B
05/27
Vital Nutrients Aller-C
100
693465524114,
693465000083
25E04, 25E04-A,
25E04-B
05/27

The impacted lots were distributed from September 2025 to March 2026.

The allergens were discovered as part of routine internal testing and promptly reported by the company to the FDA. No illnesses have been reported to date in connection with this product.

Consumers who have purchased this product are asked to immediately discontinue use and return the product to Blueroot Health for a replacement product. Consumers with questions may contact Blueroot Health at (888) 328-9992 Monday through Friday 8:00am – 7:00pm, or support@vitalnutrients.co.

View full recall information here.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions